Literature DB >> 28784216

Anesthesia Management of Organ Donors.

Victor W Xia1, Michelle Braunfeld2.   

Abstract

The shortage of suitable organs is the biggest obstacle for transplants. At present, most organs for transplant in the United States are from donation after neurologic determination of death (brain death). Potential organs for transplant need to maintain their viability during a series of insults, including the original disease, physiologic derangements during the dying process, ischemia, and reperfusion. Proper donor management before, during, and after procurement has potential to increase the number and quality of organs from donors. Anesthesiologists need to understand the physiologic derangements associated with brain death and the updated donor management during the periprocurement period.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain death; Ischemia and reperfusion injury; Organ donor; Organ transplant; Standardized donor management

Mesh:

Year:  2017        PMID: 28784216     DOI: 10.1016/j.anclin.2017.04.003

Source DB:  PubMed          Journal:  Anesthesiol Clin        ISSN: 1932-2275


  3 in total

1.  The Amide Local Anesthetic Ropivacaine Attenuates Acute Rejection After Allogeneic Mouse Lung Transplantation.

Authors:  Tatsuo Maeyashiki; Jae-Hwi Jang; Florian Janker; Yoshito Yamada; Ilhan Inci; Walter Weder; Tobias Piegeler; Wolfgang Jungraithmayr
Journal:  Lung       Date:  2019-02-09       Impact factor: 2.584

2.  Anesthetic Considerations in Facial Transplantation: Experience at NYU Langone Health and Systematic Review.

Authors:  Allyson R Alfonso; Elie P Ramly; Rami S Kantar; William J Rifkin; J Rodrigo Diaz-Siso; Bruce E Gelb; Joseph S Yeh; Mark F Espina; Sudheer K Jain; Greta L Piper; Eduardo D Rodriguez
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-08-17

3.  The brain-dead donor: An anaesthesiologist's perspective.

Authors:  Vijay L Shetty; Shivaji S Mali; Sangeeta V Shetty; Prajakta D Shinde
Journal:  Indian J Anaesth       Date:  2017-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.